Skip to main content
Top
Published in: Acta Diabetologica 9/2019

01-09-2019 | Obesity | Original Article

Contribution of epicardial and abdominopelvic visceral adipose tissues in Chinese adults with impaired glucose regulation and diabetes

Authors: SiMin Wang, ZhenXun Wang, ChiHua Chen, Lan Zhu, ShengJia Gu, Le Qin, BoRan Pang, FuHua Yan, WenJie Yang

Published in: Acta Diabetologica | Issue 9/2019

Login to get access

Abstract

Aims

To quantify epicardial adipose tissue (EAT) and visceral adipose tissue (VAT) in Chinese adults with impaired glucose regulation (IGR) or diabetes and compare the contributions of EAT and VAT to the occurrence of IGR and diabetes with those of traditional obesity indices.

Methods

Cardiac and abdominopelvic noncontrast computed tomographic images of 668 individuals were used to measure EAT and VAT volume. Multivariable logistic regression and area under the receiver operating characteristic (ROC) curve were used to illustrate the contributions of these tissues.

Results

Patients with IGR or diabetes had larger EAT and VAT volumes than did the controls, and the VAT volume was significantly different between the IGR and diabetic groups. In multivariable models, higher EAT or VAT volume was positively associated with the presence of IGR and diabetes. After adjusting further for body mass index (BMI) and waist-to-hip ratio (WHR), a higher EAT volume was still positively associated with IGR (odds ratio (OR) = 1.46; 95% confidence interval (CI), 1.04–2.03), and a higher VAT volume was positively associated with IGR (OR = 1.86; 95% CI, 1.15–3.02) and diabetes (OR = 1.86; 95% CI, 1.16–2.99). The areas under the curve (AUCs) of the association of EAT (AUC = 0.751; 95% CI, 0.712–0.789) and VAT (AUC = 0.752; 95% CI, 0.713–0.792) with dysglycemia (IGR + diabetes) were significantly larger than those of the traditional obesity indices (all P < 0.05).

Conclusions

High EAT or VAT volume is positively associated with IGR and diabetes in Chinese adults. With a given WHR and BMI, such an association still exists to some extent. The correlation may be stronger than those of the traditional obesity indices.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hu C, Jia W (2018) Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes 67:3–11CrossRef Hu C, Jia W (2018) Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes 67:3–11CrossRef
2.
go back to reference Aldworth J, Patterson C, Jacobs E, Misra A, Snouffer EB, Piemonte L et al (2017) International diabetes federation, 8th edn. IDF Diabetes Atlas, Brussels Aldworth J, Patterson C, Jacobs E, Misra A, Snouffer EB, Piemonte L et al (2017) International diabetes federation, 8th edn. IDF Diabetes Atlas, Brussels
3.
go back to reference James C, Bullard KM, Rolka DB, Geiss LS, Williams DE, Cowie CC et al (2011) Implications of alternative definitions of prediabetes for prevalence in U.S. adults. Diabetes Care 34:387–391CrossRef James C, Bullard KM, Rolka DB, Geiss LS, Williams DE, Cowie CC et al (2011) Implications of alternative definitions of prediabetes for prevalence in U.S. adults. Diabetes Care 34:387–391CrossRef
4.
go back to reference Nathan DM, Davidson MB, Defronzo RA, Heine RJ, Henry RR, Pratley R et al (2007) Impaired fasting glucose and impaired glucose tolerance implications for care. Diabetes Care 30:753–759CrossRef Nathan DM, Davidson MB, Defronzo RA, Heine RJ, Henry RR, Pratley R et al (2007) Impaired fasting glucose and impaired glucose tolerance implications for care. Diabetes Care 30:753–759CrossRef
5.
go back to reference Xu Y, Wang L, He J, Bi Y, Li M, Wang T et al (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310:948–959CrossRef Xu Y, Wang L, He J, Bi Y, Li M, Wang T et al (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310:948–959CrossRef
6.
go back to reference Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379:2279–2290CrossRef Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379:2279–2290CrossRef
7.
go back to reference Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R et al (2012) Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308:1150–1159CrossRef Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R et al (2012) Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308:1150–1159CrossRef
8.
go back to reference Smith U (2015) Abdominal obesity: a marker of ectopic fat accumulation. J Clin Investig 125:1790–1792CrossRef Smith U (2015) Abdominal obesity: a marker of ectopic fat accumulation. J Clin Investig 125:1790–1792CrossRef
9.
go back to reference Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horval P, Liu CY et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48CrossRef Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horval P, Liu CY et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48CrossRef
10.
go back to reference Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H et al (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108:2460–2466CrossRef Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H et al (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108:2460–2466CrossRef
11.
12.
go back to reference American Diabetes Association (2019) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 42(Suppl. 1):S13–S28CrossRef American Diabetes Association (2019) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 42(Suppl. 1):S13–S28CrossRef
13.
go back to reference World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. World Health Organization, Geneva World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. World Health Organization, Geneva
14.
go back to reference Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K et al (1999) Abdominal fat: standardized technique for measurement at CT. Radiology 211:283–286CrossRef Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K et al (1999) Abdominal fat: standardized technique for measurement at CT. Radiology 211:283–286CrossRef
15.
go back to reference Tian Y, Jiang C, Wang M, Cai R, Zhang Y, He Z et al (2016) BMI, leisure-time physical activity, and physical fitness in adults in China: results from a series of national surveys, 2000-14. Lancet Diabetes Endocrinol 4:487–497CrossRef Tian Y, Jiang C, Wang M, Cai R, Zhang Y, He Z et al (2016) BMI, leisure-time physical activity, and physical fitness in adults in China: results from a series of national surveys, 2000-14. Lancet Diabetes Endocrinol 4:487–497CrossRef
16.
go back to reference World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCD/NCS, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: diagnosis and classification of diabetes mellitus. WHO/NCD/NCS, Geneva
17.
go back to reference Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS et al (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample the Framingham Heart Study. Circulation 117:605–613CrossRef Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS et al (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample the Framingham Heart Study. Circulation 117:605–613CrossRef
18.
go back to reference Mahabadi AA, Masaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA et al (2009) Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30:850–856CrossRef Mahabadi AA, Masaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA et al (2009) Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30:850–856CrossRef
19.
go back to reference Iacobellis G (2015) Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 11:363–371CrossRef Iacobellis G (2015) Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 11:363–371CrossRef
20.
go back to reference Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ Brit Med J 332:73–78CrossRef Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ Brit Med J 332:73–78CrossRef
21.
go back to reference Bays HE (2011) Adiposopathy is “sick fat” a cardiovascular disease? J Am Coll Cardiol 57:2461–2473CrossRef Bays HE (2011) Adiposopathy is “sick fat” a cardiovascular disease? J Am Coll Cardiol 57:2461–2473CrossRef
22.
go back to reference Borel AL, Nazare JA, Smith J, Aschner P, Barter P, Van Gaal L et al (2015) Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance. Int J Obes (Lond) 39:495–501CrossRef Borel AL, Nazare JA, Smith J, Aschner P, Barter P, Van Gaal L et al (2015) Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance. Int J Obes (Lond) 39:495–501CrossRef
23.
go back to reference Smith JD, Borel AL, Nazare JA, Haffner SM, Balkau B, Ross R et al (2012) Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J Clin Endocrinol Metab 97:1517–1525CrossRef Smith JD, Borel AL, Nazare JA, Haffner SM, Balkau B, Ross R et al (2012) Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J Clin Endocrinol Metab 97:1517–1525CrossRef
24.
go back to reference Schwenzer NF, Machann J, Schraml C, Springer F, Ludescher B, Stefan N et al (2010) Quantitative analysis of adipose tissue in single transverse slices for estimation of volumes of relevant fat tissue compartments: a study in a large cohort of subjects at risk for type 2 diabetes by MRI with comparison to anthropometric data. Investig Radiol 45:788–794CrossRef Schwenzer NF, Machann J, Schraml C, Springer F, Ludescher B, Stefan N et al (2010) Quantitative analysis of adipose tissue in single transverse slices for estimation of volumes of relevant fat tissue compartments: a study in a large cohort of subjects at risk for type 2 diabetes by MRI with comparison to anthropometric data. Investig Radiol 45:788–794CrossRef
Metadata
Title
Contribution of epicardial and abdominopelvic visceral adipose tissues in Chinese adults with impaired glucose regulation and diabetes
Authors
SiMin Wang
ZhenXun Wang
ChiHua Chen
Lan Zhu
ShengJia Gu
Le Qin
BoRan Pang
FuHua Yan
WenJie Yang
Publication date
01-09-2019
Publisher
Springer Milan
Keywords
Obesity
Obesity
Published in
Acta Diabetologica / Issue 9/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-019-01348-z

Other articles of this Issue 9/2019

Acta Diabetologica 9/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.